Glutathione and Glutathione Delivery Compounds

Advances in Pharmacology

Volumn 38, Issue C, 1996, Pages 65-78

  Anderson, Mary E ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2042501244     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)60979-5     Document Type: Article

References (70)

1. Anderson M.E. Preparation of γ-glutamyl amino acids by chemical and enzymatic methods. Methods Enzymol. 113 (1985) 555-564
2. Anderson M.E., Levy E.J., and Meister A. Preparation and use of glutathione monoesters. Methods Enzymol. 234 (1994) 492-499
3. Anderson M.E., and Meister A. Transport and direct utilization of γ- glutamylcyst(e)ine for glutathione synthesis. Proc. Natl. Acad. Sci. U.S.A. 91 (1983) 707-711
4. Anderson M.E., and Meister A. Intracellular delivery of cysteine. Methods Enzymol. 143 (1987) 313-32S
5. Anderson M.E., and Meister A. Marked increase of cysteine levels in many regions of the brain after administration of 2-oxothiazolidine-4-carboxylate. FASEB J. 3 (1989) 1632-1636
6. Anderson M.E., and Meister A. Glutathione monoesters. Anal. Biochem. 183 (1989) 16-20
7. Anderson M.E., Powrie F., Puri R.N., and Meister A. Glutathione monoethyl ester: Preparation, uptake by tissues, and conversion to glutathione. Arch. Biochem. Biophys. 239 (1985) 538-548
8. Anderson M.E., Underwood M., Bridges R.J., and Meister A. Glutathione metabolism at the blood-cerebrospinal fluid barrier. FASEB J. 3 (1989) 2527-2531
9. Breborowicz A., Witowski J., Martis L., and Oreopoulos D.G. Enhancement of viability of human peritoneal mesothelial cells with glutathione precursor: L-2- Oxothiazolidine-4-carboxylate. Adv. Periton. Dialy. 9 (1993) 21-24
10. Buhl R., Holroyd K.J., Mastrangeli A., Cantin A.M., Jaffe H.A., Wells F.B., Saltini C., and Crystal R.G. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet ii (1989) 1294-1298
11. Calvin H.L., Medvedovsky C., and Worgul B.V. Near-total glutathione depletion and age-specific cataracts induced by buthionine sulfoximine in mice. Science 233 (1986) 553-555
12. Cantin A.M., Hubbard R.C., and Crystal R.G. Glutathone deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 139 (1989) 370-372
13. Cooper A.J.L., Haber M.T., and Meister A. On the chemistry and biochemistry of 3-mercaptopyruvate acid, the α-keto acid analog of cysteine. J. Biol. Chem. 257 (1982) 816-826
14. In: Cutler R.G., Packer L., Bertram, and Mori A. (Eds). "Oxidative Stress and Aging" (1995), Birkhauser Verlag, Boston
15. Fxk H.-P., Grnuender H., Hartrnann M., Petzoldt D., Daniel V., and Droege W. Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol. Chem. Hoppe Seyler 370 (1989) 101-108
16. Fields J.A., Keshavarzian A., Eiznhamer D., Frommel T., Winship D., and Holmes E.W. Low levels of blood and colonic glutathione in ulcerative colitis. Gastroenterotogy 106 (1994) A680
17. Forrester T.E., Badaloo V., Bennett F.I., and Jackson A.A. Excessive excretion of 5-oxoproline and decreased levels of blood glutathione in type II diabetes mellitus. Eur. J. Clin. Nutr. 44 (1990) 847-850
18. Ginter E. Marginal vitamin C deficiency, lipid metabolism, and atherogenesis. Adv. Lipid Res. 16 (1978) 167-220
19. Gotoh O., Yamamoto M., Tamura A., and Sano K. Effect of YM737, a new glutathione analog, on ischemic brain edema. Acta Neurochir. 60 Suppl. (1994) 318-320
20. Griffith O.W., Anderson M.E., and Meister A. Inhibition of glutathione biosynthesis by prothionine (S-n-propyl homocysteine sulfoximine), a selective inhibitor of γ-glutamylcysteine synthetase. J. Biol. Chem. 254 (1979) 1205-1210
21. Griffith O.W., and Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J. Biol. Chem. 254 (1979) 7558-7560
22. Jain A., Madsen D.C., Auld P.A.M., Frayer W.W., Schwartz M.K., Meister A., and Martensson J. L-2-Oxothiazolidine-4-carboxyIate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet. J. Nutr. 125 (1995) 851-856
23. Josephs, S., Asuncion, C., Sun, C., Jacobson, P., and Webb, L. (1993). Procysteine (L-2- oxothiazolidine-4-carboxylic acid) reduces the toxicity of AZT (zidovudine) and enhances the antiviral activity of AZT in cultured peripheral blood mononculear cells (PBMC). In IXth International Conference on AIDS (June 6-11, 1993, Berlin), 1. [Abstract 2301.
24. Kalayjian R.C., Skowron G., Emgushov R.-T., Chance M., Spell S.A., Borum P.R., Webb L.S., Mayer K.H., Jackson J.B., Yen-Lieberman B., Story K.O., Rowe W.B., Thompson K., Goldberg D., Trimbo S., and Lederman M.M. A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects. J. Acq. Immune Def. Syndr. 7 (1994) 369-374
25. Kalebic T., Kinter A., Poli G., Anderson M.E., Meister A., and Fauci A.S. Suppression of HIV expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetyl cysteine. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 896-990
26. Karlsen R.L., Grofava I., Malthe-Sorensen D., and Fornum E. Morphological changes in rat brain induced by L-cysteine injection in newborn animals. Exp. Brain Res. 208 (1981) 167-180
27. Lederman M.M., Georger D., Dando S., Schmelzer R., Averill L., and Goldberg D. L-2-Oxothiazolidine-4-carboxylic acid (procysteine) inhibits expression of the human immunodeficiency virus and expression of the interleukin-2 receptor alpha chain. J. Acq. Immune Def. Syndr. 8 (1995) 107-115
28. Levy E.J., Anderson M.E., and Meister A. Transport of glutathione diethyl ester into human cells. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 9171-9175
29. Levy E.J., Anderson M.E., and Meister A. Preparation and properties of glutathione diethyl ester and related derivatives. Methods Enzymol. 234 (1994) 499-505
30. Martensson A., Goodwin C.W., and Blake R. Mitochondrial glutathione in hyper-metabolic rats following burn injury and thyroid hormone administration: Evidence of a selective effect on brains glutathione by burn injury. Metabolism 41 (1992) 273-277
31. Martensson J., Han J., Griffitb O.W., and Meister A. Glutathione ester delays the onset of scurvy in ascorbate-deficient guinea pigs. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 317-321
32. Martensson J., Jain A., Stole E., Frayer W., Auld P.A.M., and Meister A. Inhibition of glutathione synthesis in the newborn rat: A model for endogenously produced oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9360-9364
33. Martensson J., and Meister A. Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 471-475
34. Martensson J., and Meister A. Glutathione deficiency decreases tissue ascorbate levels in newborn rats: Ascorbate spares glutathione and protects. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4656-4660
35. Martinez-Cayuela M. Oxygen free radicals and human disease. Biocbimie 77 (1995) 147-161
36. Meister A. Metabolism and function of glutathione. In: Dolphin D., Poulson R., and Avramovic O. (Eds). "Glutathione: Chemical, Biochemical and Medical Aspects" (1989), Wiley, New York 367-474
37. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal; applications in research and therapy. Pharmacol. Therap. 51 (1991) 155-194
38. Meister A. On the antioxidant effects of ascorbic acid and glutathione. Biochem. Pharmacol. 44 (1992) 1905-1915
39. Meister A. Glutathione-ascorbate acid antioxidant system in animals. J. Biol. Chem. 269 (1994) 9397-9400
40. Meister A. Strategies for increasing cellular glutathione. In: Packer L., and Cadenas E. (Eds). "Biothiols in Health and Disease" (1995), Dekker, New York 165-188
41. Meister A., and Anderson M.E. Glutathione. Annu. Rev. Biochem. 52 (1983) 711-760
42. Meister A., Anderson M.E., and Hwang O. Intracellular delivery of cysteine and glutathione delivery systems. J. Am. Coll. Nutr. 5 (1986) 137-151
43. Meister A., and Larsson A. Glutathione synthetase deficiency and other disorders of the γ-glutamyl cycle. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). "The Metabolic Basis of Inherited Disease". 7th Ed. (1994), McGraw Hill, New York 1461-1477
44. Mnhas H., and Thornalley P.J. Comparison of the delivery of reduced glutathione into P388D, cells by reduced glutathione and its mono- and diethyl ester derivatives. Biochem. Pharmacol. 49 (1995) 1475-1482
45. Nishiuch Y., Sasaki M., Nakayasu M., and Oikawa A. Cytotoxicity of cysteine in culture media. In Vitro 12 (1976) 635
46. Olney J.W., Ho O.-L., and Rhee V. Cytotoxic effect of acid and sulphur containing amino acids on the infant mouse central nervous system. Brain Res. 14 (1971) 61-76
47. Pace G.W., and Leaf C.D. The role of oxidative stress in HIV disease. Free Rad. Biol. Med. 19 (1995) 523-528
48. Pacht E.R., Timerman A.P., Lykens M.G., and Merola A.J. Deficiency of alveolar fluid glutathione in patients with sepsis and the adult respiratory distress syndrome. Chest 100 (1991) 1397-1403
49. In: Packer L., and Cadenas E. (Eds). "Biothiols in Health and Disease" (1995), Dekker, New York
50. Pileblad E., and Magnusson T. Increase in rat brain glutathione following intracerebro-ventricular administration of y-glutamylcysteine. Biochem. Pharmacol. 44 (1992) 895-903
51. Porta P., Aebi S., Summer K., and Lauterburg B.H. L-2-Oxothiazolidine-4-carboxylic acid, a cysteine prodrug: Pharmacokinetics and effects on thiols in plasma and lymphocytes in human. J. Pharmacol. Exp. Ther. 257 (1991) 331-334
52. Puri R.N., and Meister A. Transport of glutathione, as γ-glutamylcysteinylglycyl ester, into liver and kidney. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 5258-5260
53. Richman P.G., and Meister A. Regulation of γ-glutamylcysteine synthetase by nonallo-steric feedback inhibition by glutathione. J. Biol. Chem. 250 (1973) 1422-1426
54. Sabeh F., Baxter C.R., and Norton S.J. Skin burn injury and oxidative stress in liver and lung tissues of rabbit models. Eur. J. Clin. Chem. Clin. Biochem. 33 (1995) 323-328
55. Scadutto Jr. R.C., Gattone II V.H., Grotyohann L.W., Wertz J., and Martin L.F. Effect of an altered glutathione content on renal ischemic injury. Am. J. Physiol. 255 (1988) F911-F921
56. Shibata S., Tominaga K., and Watanabe S. Glutathione protects against hypoxic/hypoglycemic decreases in 2-deoxyglucose uptake and presynaptic spikes in hippocampal slices. Eur. J. Pharmacol. 273 (1995) 191-195
57. Shug A.L., and Madsen D.C. Protection of the ischemic rat heart by procysteine and amino acids. J. Nutr. Biochem. 5 (1994) 356-359
58. Suarez M., Beloqui O., Ferrer J.V., Fil B., Qian C., Garcia N., Civeira P., and Prieto J. Glutathione depletion in chronic hepatitis C. Int. Hepatol. Commun. 1 (1993) 215-221
59. Suthanthiran M., Anderson M.E., Sharma V.K., and Meister A. Glutathione regulates activation-dependent DNA synthesis in highly purified T lymphocytes stimulated via CD2 and CD3 Antigens. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 3343-3347
60. Tsan M.-F., White J.E., and Rosano C.L. Modulation of endothelial GSH concentrations: Effect of exogenous GSH and GSH monoethyl ester. J. Appl. Physiol. 66 (1989) 1029-1034
61. Vos O., and Roos-Verhey W.S.D. Endogenous versus exogenous thiols in radioprotection. Pharmacol. Ther. 39 (1988) 169-177
62. Weitberg A.B. The effect of L-2-oxothiazolidine on glutathione levels in cultured mammalian cells. Mutat. Res. 191 (1987) 189-191
63. Wellner V.P., Anderson M.E., Puri R.N., Jensen G.L., and Meister A. Radioprotection by glutathione ester: Transport of glutathione ester into human lymphoid cells and fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 4732-4735
64. Wells W.W., Xu D.P., Yang Y., and Rocque P.A. Mammalian thioltransferase (glutaredoxin) and protein disulfide isomerase have dehydroascorbate reductase activity. J. Biol. Chem. 265 (1990) 15361-15364
65. Wells W.W., Yang Y., Deits T.L., and Gan Z.-R. Thioltransferases. Adv. Enzymol. 66 (1992) 149-201
66. Williamson J.M., Boettcher B., and Meister A. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis. Proc. Natl. Acad. Sci. U.S.A. 79 (1982) 6246-6249
67. Williamson J.M., and Meister A. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 936-939
68. Williamson J.M., and Meister A. New substrates of S-oxo-L-prolinase. J. Biol. Chem. 257 (1982) 12039-12042
69. Willis G.C. An experimental study of the intimal ground substance in atherosclerosis. Can. Med. Assoc. J. 69 (1953) 17-22
70. Wilson, D. M., White, R. D., Webb, L. E., Bender, J. G., Pippin, L. L., and Goldberg, D. L. (1993). Amelioration of AZT-induced bone marrow hypoplasia in mice cotreated with glutathione prodrug, procysteine. In "IXth International Conference onAIDS (June 7-11, 1993, Berlin). [Abstract]